XBiotech Inc. - Common Shares, no par value (XBIT)

Historical Holders from Q2 2015 to Q1 2025

Symbol
XBIT on Nasdaq
CUSIP
98400H102
Type / Class
Equity / Common Shares, no par value
Shares outstanding
30.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
4.72M
Holdings value
$18.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
52
Number of buys
27
Number of sells
-16
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of XBiotech Inc. - Common Shares, no par value (XBIT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SIMARD JOHN 19.9% $21.5M 6.62M John Simard Dec 31, 2024
MCKENZIE W THORPE 9.71% $9.68M 2.99M W. Thorpe McKenzie Dec 31, 2024

Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 32.8K $106K -$1.49K $3.24 2
2024 Q4 4.72M $18.6M -$1.61M $3.95 52
2024 Q3 4.85M $37.5M +$1.65M $7.73 49
2024 Q2 4.52M $23.2M +$2.72M $5.14 45
2024 Q1 3.99M $32.5M +$4.76M $8.13 44
2023 Q4 3.45M $13.8M +$111K $4.00 37
2023 Q3 3.4M $14M -$310K $4.12 37
2023 Q2 3.48M $20.7M +$5.85M $5.94 37
2023 Q1 2.49M $8.6M -$921K $3.45 33
2022 Q4 2.76M $9.67M -$1.05M $3.51 37
2022 Q3 3.05M $11M -$1.56M $3.62 40
2022 Q2 3.36M $18.9M -$4.74M $5.63 48
2022 Q1 3.96M $34.2M -$2M $8.64 55
2021 Q4 3.97M $44.1M -$1.9M $11.13 51
2021 Q3 4.34M $56.3M +$4.06M $12.95 64
2021 Q2 4.02M $66.5M -$4.43M $16.56 55
2021 Q1 4.29M $73.5M +$5.86M $17.17 62
2020 Q4 3.92M $61.4M +$428K $15.65 61
2020 Q3 3.87M $73.8M -$5.83M $19.09 65
2020 Q2 4.27M $58.6M -$399K $13.71 60
2020 Q1 4.36M $46.3M -$15.9M $10.62 56
2019 Q4 5.47M $102M +$15.8M $18.67 57
2019 Q3 4.9M $51.3M +$5.93M $10.46 43
2019 Q2 4.41M $33.4M +$13.2M $7.58 42
2019 Q1 2.55M $28.1M +$16.1M $11.02 36
2018 Q4 1.11M $5.63M -$1.83M $5.08 21
2018 Q3 1.52M $4.84M -$1.07M $3.18 20
2018 Q2 1.78M $7.96M -$6.16M $4.48 28
2018 Q1 3.17M $16.9M -$559K $5.35 41
2017 Q4 3.29M $13M -$2.27M $3.94 41
2017 Q3 3.88M $17M +$660K $4.37 44
2017 Q2 3.71M $17.4M -$1.95M $4.70 41
2017 Q1 3.6M $59.3M +$24.2M $16.48 47
2016 Q4 3.46M $35M +$1.33M $10.12 47
2016 Q3 3.29M $44.3M +$5.76M $13.46 47
2016 Q2 2.79M $58.4M +$31.4M $20.92 46
2016 Q1 1.32M $12.5M -$436K $9.45 32
2015 Q4 1.35M $14.6M +$5.58M $10.87 34
2015 Q3 764K $11.4M +$2.3M $14.94 30
2015 Q2 571K $10.3M +$10.3M $18.09 30